stockrowModerna, Inc. (MRNA) vs Revolution Medicines, Inc. (RVMD)
- Moderna, Inc. MRNA 260.20 +7.76%
- Revolution Medicines, Inc. RVMD 192.27 +8.23%
Moderna, Inc. and Revolution Medicines, Inc. are both Biotechnology companies. Moderna, Inc. is the larger, with a market value of $96.4B against $38.1B — 2.5× the size. Revolution Medicines, Inc. grew revenue faster over the last twelve months: 491.1% against −27.6%. Moderna, Inc. has the higher net margin (−141.4% vs −894.4%) and the lower return on invested capital (−93.5% vs 0.00%). Across the 18 metrics below, Moderna, Inc. leads on 12 and Revolution Medicines, Inc. on 6.
Valuation
Profitability
| Metric | MRNA | RVMD | Biotechnology median |
|---|---|---|---|
| Gross margin | 23.38% | 95.62% | 65.16% |
| Operating margin | (149.01%) | (805.75%) | 0.00% |
| Net margin | (141.43%) | (894.40%) | 0.00% |
| Free cash flow margin | (55.83%) | (688.93%) | 0.00% |
| Return on equity | (39.00%) | (93.56%) | (50.12%) |
| Return on assets | (27.43%) | (57.07%) | (45.60%) |
| Return on invested capital | (93.47%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack